Romidepsin Price Inquiry and Purchasing Channel Guide

Romidepsin (Romidepsin), trade name Istodax, is a highly effective drug specially used to treat relapsed and refractory cutaneous T-cell lymphoma (CTCL) and peripheral T-cell lymphoma (PTCL). It changes the expression pattern of genes through a unique mechanism, namely inhibiting the activity of histone deacetylase (HDAC), thereby inducing tumor cell cycle arrest and apoptosis.

Romidepsin was approved by the US FDA in 2009 and has become an important option for the treatment of relapsed and refractory CTCL. Subsequently, in 2011, its indications were expanded to second-line treatment of PTCL, further consolidating its position in the field of lymphoma treatment. As a histone deacetylase inhibitor, romidepsin can increase the accumulation of acetylated histones in tumor cells, thereby effectively inhibiting the growth and spread of cancer cells.

In clinical application, romidepsin has shown remarkable efficacy. Clinical trial data show that for patients with relapsed PTCL, the overall response rate of romidepsin monotherapy can reach 61%, and the response rate is even higher when combined with other drugs. In addition, the effectiveness of romidepsin has been verified in Asian populations.

However, the use of romidepsin comes with certain risks. Common adverse reactions include thrombocytopenia, nausea, electrocardiogram abnormalities, etc., which need to be monitored and treated under the guidance of a professional doctor. At the same time, due to the risk of QT prolongation, it is necessary to ensure that the patient's potassium and magnesium are within the normal range before use.

Romidepsin is not yet on the market in China, which means that domestic patients cannot directly purchase this drug for the time being. We learned that this drug is also difficult to obtain easily and expensive overseas, costing approximately $3,000. If the patient has a need for this drug, it is recommended to contact Yaofenxiang’s medical consultant for consultation. In general, romidepsin plays an increasingly important role in the treatment of lymphoma due to its unique efficacy and safety.

Reference link: https://www.drugs.com/mtm/romidepsin.html